Chris Abbott advises companies on complex antitrust matters, including high-stakes mergers, government investigations, and class action litigation. With experience in both government and private practice, Chris helps clients navigate regulatory scrutiny, mitigate risk, and achieve business objectives. He works with clients across the healthcare, technology, agriculture, and private equity industries, offering strategic, practical guidance throughout the deal life cycle and in contentious antitrust proceedings. He also counsels companies on compliance and the antitrust implications of day-to-day business decisions, helping them proactively manage exposure, particularly in matters involving sensitive competition issues and high regulatory scrutiny.
Chris brings significant experience advising on mergers and acquisitions, guiding clients from initial antitrust risk assessment through advocacy before the Federal Trade Commission (FTC) and Department of Justice (DOJ) to secure regulatory clearance. Drawing on his experience in the FTC's Bureau of Competition, Chris provides strategic insight into government enforcement priorities and investigative processes, allowing him to seamlessly represent clients in parallel civil and criminal investigations.